Variant report

Variant	nsv1040152
Chromosome Location	chr11:113258065-113285916
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr11:113267439-113267792	GM12878	blood:	n/a	n/a
2	BACH1	chr11:113258588-113258785	H1-hESC	embryonic stem cell:	n/a	n/a
3	CEBPB	chr11:113278460-113278586	HepG2	liver:	n/a	chr11:113278529-113278540
4	CEBPB	chr11:113263436-113263573	Hela-S3	cervix:	n/a	chr11:113263454-113263465 chr11:113263455-113263464 chr11:113263455-113263464 chr11:113263453-113263466 chr11:113263453-113263464 chr11:113263455-113263464 chr11:113263452-113263469 chr11:113263455-113263464
5	CEBPB	chr11:113263303-113263618	A549	lung:	n/a	chr11:113263454-113263465 chr11:113263455-113263464 chr11:113263455-113263464 chr11:113263453-113263466 chr11:113263453-113263464 chr11:113263455-113263464 chr11:113263452-113263469 chr11:113263455-113263464
6	CEBPB	chr11:113263365-113263539	H1-hESC	embryonic stem cell:	n/a	chr11:113263454-113263465 chr11:113263455-113263464 chr11:113263455-113263464 chr11:113263453-113263466 chr11:113263453-113263464 chr11:113263455-113263464 chr11:113263452-113263469 chr11:113263455-113263464
7	CEBPB	chr11:113263286-113263591	K562	blood:	n/a	chr11:113263454-113263465 chr11:113263455-113263464 chr11:113263455-113263464 chr11:113263453-113263466 chr11:113263453-113263464 chr11:113263455-113263464 chr11:113263452-113263469 chr11:113263455-113263464
8	CEBPB	chr11:113272310-113272874	MCF-7	breast:	n/a	chr11:113272535-113272546 chr11:113272535-113272548
9	CEBPB	chr11:113272386-113272825	Hela-S3	cervix:	n/a	chr11:113272535-113272546 chr11:113272535-113272548
10	CEBPB	chr11:113258666-113259051	H1-hESC	embryonic stem cell:	n/a	n/a
11	CEBPB	chr11:113272326-113272752	MCF-7	breast:	n/a	chr11:113272535-113272546 chr11:113272535-113272548
12	CEBPB	chr11:113272330-113272708	ECC-1	luminal epithelium:	n/a	chr11:113272535-113272546 chr11:113272535-113272548
13	CEBPB	chr11:113263931-113264169	HepG2	liver:	n/a	chr11:113264042-113264053
14	CEBPB	chr11:113272437-113272662	A549	lung:	n/a	chr11:113272535-113272546 chr11:113272535-113272548
15	CEBPB	chr11:113263286-113263638	HepG2	liver:	n/a	chr11:113263454-113263465 chr11:113263455-113263464 chr11:113263455-113263464 chr11:113263453-113263466 chr11:113263453-113263464 chr11:113263455-113263464 chr11:113263452-113263469 chr11:113263455-113263464
16	CEBPB	chr11:113272450-113272624	IMR90	lung:	n/a	chr11:113272535-113272546 chr11:113272535-113272548
17	CEBPB	chr11:113263273-113263635	IMR90	lung:	n/a	chr11:113263454-113263465 chr11:113263455-113263464 chr11:113263455-113263464 chr11:113263453-113263466 chr11:113263453-113263464 chr11:113263455-113263464 chr11:113263452-113263469 chr11:113263455-113263464
18	CHD2	chr11:113258422-113258928	H1-hESC	embryonic stem cell:	n/a	n/a
19	CHD2	chr11:113272466-113272704	Hela-S3	cervix:	n/a	n/a
20	CREB1	chr11:113258326-113258965	H1-hESC	embryonic stem cell:	n/a	n/a
21	CREB1	chr11:113258378-113259026	H1-hESC	embryonic stem cell:	n/a	n/a
22	CTBP2	chr11:113258426-113258957	H1-hESC	embryonic stem cell:	n/a	n/a
23	CTCF	chr11:113258636-113258855	Pancreas_OC	pancreas:	n/a	n/a
24	CTCF	chr11:113258640-113258790	GM12875	blood:	n/a	n/a
25	CTCF	chr11:113258680-113258830	HCPEpiC	choroid plexus:	n/a	n/a
26	CTCF	chr11:113281450-113281660	K562	blood:	n/a	n/a
27	CTCF	chr11:113258739-113258792	A549	lung:	n/a	n/a
28	CTCF	chr11:113258641-113258838	GM20000	blood:	n/a	n/a
29	CTCF	chr11:113259045-113259099	GM20000	blood:	n/a	n/a
30	CTCF	chr11:113258500-113258650	HFF-Myc	foreskin:	n/a	n/a
31	CTCF	chr11:113258680-113258830	GM12871	blood:	n/a	n/a
32	CTCF	chr11:113258640-113258790	HCM	heart:	n/a	n/a
33	CTCF	chr11:113258740-113258890	HCM	heart:	n/a	n/a
34	CTCF	chr11:113281460-113281610	K562	blood:	n/a	n/a
35	CTCF	chr11:113258640-113258790	HBMEC	blood vessel:	n/a	n/a
36	CTCF	chr11:113258700-113258850	RPTEC	kidney:	n/a	n/a
37	CTCF	chr11:113258640-113258790	GM12869	blood:	n/a	n/a
38	CTCF	chr11:113258680-113258830	HMF	breast:	n/a	n/a
39	CTCF	chr11:113258740-113258890	HFF-Myc	foreskin:	n/a	n/a
40	CTCF	chr11:113258720-113258870	NHEK	skin:	n/a	n/a
41	CTCF	chr11:113258704-113258755	Lung_OC	lung:	n/a	n/a
42	CTCF	chr11:113281525-113281579	GM12891	blood:	n/a	n/a
43	CTCF	chr11:113258720-113258870	GM12864	blood:	n/a	n/a
44	CTCF	chr11:113258602-113258835	K562	blood:	n/a	n/a
45	CTCF	chr11:113258660-113258810	HEEpiC	esophagus:	n/a	n/a
46	CTCF	chr11:113258339-113259005	HCT-116	colon:	n/a	n/a
47	CTCF	chr11:113258740-113258890	HA-sp	spinal cord:	n/a	n/a
48	CTCF	chr11:113258640-113258790	HRE	kidney:	n/a	n/a
49	CTCF	chr11:113258616-113258876	GM12891	blood:	n/a	n/a
50	CTCF	chr11:113258700-113258850	HPAF	blood vessel:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:113258444-113258494	HCPEpiC	choroid plexus:	n/a
2	chr11:113258223-113258273	IMR90	lung:	fetal
3	chr11:113258444-113258494	HCPEpiC	choroid plexus:	n/a
4	chr11:113258223-113258273	IMR90	lung:	fetal
5	chr11:113269843-113269893	HEEpiC	esophagus:	n/a
6	chr11:113258277-113258327	PANC-1	pancreas:	n/a
7	chr11:113258455-113258505	MCF10A-Er-Src	breast:	n/a
8	chr11:113258908-113258958	PFSK-1	brain:	n/a
9	chr11:113262625-113262675	Hela-S3	cervix:	n/a
10	chr11:113258390-113258440	NT2-D1	testis:	n/a
11	chr11:113262625-113262675	BJ	skin:	n/a
12	chr11:113283595-113283645	Hepatocyte	liver:	n/a
13	chr11:113258908-113258958	HCF	heart:	n/a
14	chr11:113258444-113258494	K562	blood:	n/a
15	chr11:113258223-113258273	NT2-D1	testis:	n/a
16	chr11:113258210-113258260	CMK	blood:	n/a
17	chr11:113280570-113280620	PANC-1	pancreas:	n/a
18	chr11:113280570-113280620	GM06990	blood:	n/a
19	chr11:113258750-113258800	Hela-S3	cervix:	n/a
20	chr11:113285594-113285644	ovcar-3	ovarian:	n/a
21	chr11:113269843-113269893	IMR90	lung:	fetal
22	chr11:113258455-113258505	SK-N-MC	brain:	n/a
23	chr11:113258444-113258494	AG09319	gingival:	n/a
24	chr11:113280570-113280620	LNCaP	prostate:	n/a
25	chr11:113285594-113285644	AG10803	skin:	n/a
26	chr11:113258390-113258440	HRE	kidney:	n/a
27	chr11:113262625-113262675	NHDF-neo	bronchial:	n/a
28	chr11:113271004-113271054	HRPEpiC	eye:	n/a
29	chr11:113258750-113258800	PFSK-1	brain:	n/a
30	chr11:113258223-113258273	MCF-7	breast:	n/a
31	chr11:113258390-113258440	NB4	blood:	n/a
32	chr11:113258750-113258800	HAEpiC	amniotic membrane:	n/a
33	chr11:113271004-113271054	H1-hESC	embryonic stem cell:	embryo
34	chr11:113258908-113258958	GM06990	blood:	n/a
35	chr11:113258277-113258327	HRPEpiC	eye:	n/a
36	chr11:113258223-113258273	U87	brain:	n/a
37	chr11:113280570-113280620	HCM	heart:	n/a
38	chr11:113258444-113258494	GM12892	blood:	n/a
39	chr11:113285594-113285644	HCT-116	colon:	n/a
40	chr11:113271004-113271054	SK-N-SH_RA	brain:	n/a
41	chr11:113285594-113285644	HNPCEpiC	eye:	n/a
42	chr11:113283595-113283645	HL-60	blood:	n/a
43	chr11:113258455-113258505	IMR90	lung:	fetal
44	chr11:113258390-113258440	HepG2	liver:	n/a
45	chr11:113258455-113258505	Jurkat	blood:	n/a
46	chr11:113258390-113258440	U87	brain:	n/a
47	chr11:113258750-113258800	PrEC	prostate:	n/a
48	chr11:113258390-113258440	GM12878	blood:	n/a
49	chr11:113271004-113271054	HEEpiC	esophagus:	n/a
50	chr11:113258277-113258327	HNPCEpiC	eye:	n/a

No.	Distal block	Cell Line	Cell type
1	chr11:113218541..113222017-chr11:113284128..113288012,3	K562	blood:
2	chr11:113277794..113280579-chr11:113282730..113285609,2	K562	blood:
3	chr11:113258598..113259272-chr11:113403105..113403848,2	K562	blood:
4	chr11:113282501..113284642-chr11:113290868..113293488,2	K562	blood:
5	chr11:113254251..113256495-chr11:113260373..113262197,2	K562	blood:
6	chr11:113277794..113280579-chr11:113282730..113285609,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-DRD2-4	chr11:113276482-113278538	NONHSAT024247
2	lnc-ANKK1-1	chr11:113276610-113276689	ENSG00000256757.1
3	lnc-ANKK1-1	chr11:113282747-113282839	ENSG00000256757.1
4	lnc-ANKK1-1	chr11:113276043-113276206	ENSG00000256757.1
5	lnc-ANKK1-1	chr11:113282269-113282455	ENSG00000256757.1

Variant related genes	Relation type
ENSG00000256757	TF binding region
ANKK1	TF binding region
ENSG00000256757	CpG island
ANKK1	CpG island

Extended variants
information (count: 1407 )
Associated
traits (count: 108 )

Variant overlapped rSNPs/rCNVs (count:1407 , 50 per page) page: 1 2 3 4 5 6 7 ... 29

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs10891545	chr11:113258065-113258066	Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer Enhancers Active TSS Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs543390926	chr11:113258101-113258102	Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer Enhancers Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs561227329	chr11:113258131-113258132	Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer Enhancers Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs377372504	chr11:113258173-113258174	Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer Enhancers Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs576969390	chr11:113258302-113258303	Flanking Bivalent TSS/Enh Active TSS Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
6	rs545943210	chr11:113258333-113258334	Flanking Bivalent TSS/Enh Active TSS Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs559901781	chr11:113258346-113258347	Flanking Bivalent TSS/Enh Active TSS Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs528571685	chr11:113258364-113258365	Flanking Bivalent TSS/Enh Active TSS Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs371357060	chr11:113258386-113258387	Flanking Bivalent TSS/Enh Active TSS Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs562101454	chr11:113258406-113258407	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers ZNF genes & repeats	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
11	rs7929146	chr11:113258419-113258420	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers ZNF genes & repeats	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs151031287	chr11:113258421-113258422	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers ZNF genes & repeats	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
13	rs375509144	chr11:113258452-113258453	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers ZNF genes & repeats	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
14	rs373936931	chr11:113258455-113258456	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers ZNF genes & repeats	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
15	rs528322027	chr11:113258459-113258460	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers ZNF genes & repeats	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
16	rs112490516	chr11:113258492-113258493	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers ZNF genes & repeats	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
17	rs547140030	chr11:113258513-113258514	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers ZNF genes & repeats	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs369673907	chr11:113258554-113258555	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
19	rs111334073	chr11:113258563-113258564	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
20	rs566701242	chr11:113258590-113258591	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
21	rs35657708	chr11:113258616-113258617	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
22	rs371434196	chr11:113258658-113258659	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
23	rs142610545	chr11:113258699-113258700	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
24	rs201008406	chr11:113258719-113258720	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
25	rs554233180	chr11:113258722-113258723	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
26	rs534825533	chr11:113258726-113258727	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
27	rs368483324	chr11:113258733-113258734	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
28	rs567763343	chr11:113258741-113258742	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
29	rs537006404	chr11:113258744-113258745	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
30	rs111789052	chr11:113258762-113258763	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
31	rs371871655	chr11:113258777-113258778	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
32	rs181883517	chr11:113258787-113258788	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
33	rs369803292	chr11:113258796-113258797	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
34	rs545702309	chr11:113258821-113258822	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
35	rs553234761	chr11:113258822-113258823	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
36	rs562593885	chr11:113258846-113258847	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
37	rs371234207	chr11:113258954-113258955	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
38	rs531285512	chr11:113258962-113258963	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
39	rs142328839	chr11:113259000-113259001	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
40	rs113584199	chr11:113259032-113259033	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs562162745	chr11:113259034-113259035	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs530818161	chr11:113259056-113259057	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs544558347	chr11:113259123-113259124	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs115878013	chr11:113259158-113259159	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs533706000	chr11:113259178-113259179	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs377443317	chr11:113259197-113259198	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs566764295	chr11:113259205-113259206	Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs185694634	chr11:113259208-113259209	Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs147628481	chr11:113259247-113259248	Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs547885547	chr11:113259290-113259291	Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:108)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Wilms tumour	21544195	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Acute myeloid leukemia	20729466	CNVD
Cancer	21637783	CNVD
Acute myeloid leukemia	16864856	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21484798	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Glioblastoma multiforme	19960244	CNVD
Liposarcoma	21253554	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Neuroblastoma	17533364	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Glioblastoma multiforme	21080181	CNVD
Cancer	16751803	CNVD
Seminomas	18059402	CNVD
Cervical cancer	21062161	CNVD
Esophageal squamous carcinoma	18350619	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Neuroblastoma	18923191	CNVD
Cancer	22429812	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	16608533	CNVD
T-cell lymphomas	19863542	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Basal cell lymphoma	17053054	CNVD
Hepatocellular carcinoma	16785998	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21858162	CNVD
Breast cancer	21785460	CNVD
Breast cancer	21958427	CNVD
Lung cancer	18438408	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	17133270	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	17603634	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Breast cancer	21364760	CNVD
Mental retardation	19966786	CNVD
Non-small cell lung cancer	21829676	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Urothelial carcinoma	21177765	CNVD
Ovarian cancer	21720365	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Neuroblastoma	17327916	CNVD
Malignant melanoma	17260012	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Prostate cancer	16573809	CNVD
Prostate cancer	18632612	CNVD
Renal cell carcinoma	21668985	CNVD
Cancer	20164920	CNVD
Developmental delay	21147756	CNVD
Myelofibrosis	22110671	CNVD
Urothelial cell carcinoma	18451213	CNVD
Cancer	21129771	CNVD
Emanuel syndrome	21549014	CNVD
Emanuel syndrome	18184694	CNVD
Non-syndromic sensorineural hearing loss	18184694	CNVD
Acute lymphoblastic leukemia	22581003	CNVD
Ovarian neoplasms	16753589	CNVD
Chronic lymphocytic leukemia	21049055	CNVD
Cancer	21183584	CNVD
Retinoblastoma	22278416	CNVD
Myxofibrosarcoma	16751306	CNVD
Non-syndromic sensorineural hearing loss	16829213	CNVD
Non-syndromic sensorineural hearing loss	16760666	CNVD
Squamous cell cancer	20885788	CNVD
Neuroblastoma	20406844	CNVD
Renal cell carcinoma	18765545	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Neurocytoma	17123091	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Central neurocytomas	17123091	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21509527	CNVD
Congenital diaphragmatic hernia	21525063	CNVD
Mantle cell lymphoma	19029149	CNVD
Squamous cell cancer	19047905	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Multiple myeloma	16616336	CNVD
Hirschsprung''s Disease	21712996	CNVD
Non-small cell lung cancer	21385341	CNVD
Hepatocellular carcinoma	16750200	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:282 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:113240200-113258400	Weak transcription	Spleen	Spleen
2	chr11:113249200-113258200	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
3	chr11:113255400-113258200	Enhancers	HMEC	breast
4	chr11:113255400-113258400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
5	chr11:113255600-113258200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
6	chr11:113255800-113258200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
7	chr11:113256000-113258200	Weak transcription	Placenta Amnion	Placenta Amnion
8	chr11:113257000-113260200	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
9	chr11:113257400-113258200	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
10	chr11:113257400-113258200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
11	chr11:113257400-113258400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
12	chr11:113257400-113258400	Bivalent Enhancer	Fetal Stomach	stomach
13	chr11:113257600-113258200	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
14	chr11:113257600-113258200	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
15	chr11:113257600-113258200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
16	chr11:113257600-113258400	Weak transcription	Lung	lung
17	chr11:113257600-113259200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
18	chr11:113257800-113258200	Enhancers	H9 Cell Line	embryonic stem cell
19	chr11:113257800-113258200	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
20	chr11:113257800-113258200	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
21	chr11:113257800-113258400	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
22	chr11:113257800-113258800	Bivalent Enhancer	Fetal Muscle Leg	muscle
23	chr11:113258000-113258400	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell
24	chr11:113258000-113258400	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
25	chr11:113258000-113258400	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
26	chr11:113258000-113258400	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
27	chr11:113258000-113258600	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
28	chr11:113258000-113258600	Enhancers	HUVEC	blood vessel
29	chr11:113258000-113258800	Active TSS	HUES48 Cell Line	embryonic stem cell
30	chr11:113258000-113259200	Flanking Active TSS	NHEK	skin
31	chr11:113258000-113272200	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
32	chr11:113258200-113258400	Bivalent/Poised TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
33	chr11:113258200-113258400	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
34	chr11:113258200-113258400	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
35	chr11:113258200-113258400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
36	chr11:113258200-113258400	Bivalent Enhancer	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
37	chr11:113258200-113258400	Bivalent Enhancer	Primary T cells effector/memory enriched fromperipheralblood	blood
38	chr11:113258200-113258400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
39	chr11:113258200-113258400	Enhancers	Colonic Mucosa	Colon
40	chr11:113258200-113258400	Bivalent Enhancer	Duodenum Mucosa	Duodenum
41	chr11:113258200-113258400	Enhancers	Esophagus	oesophagus
42	chr11:113258200-113258400	Bivalent Enhancer	Placenta	Placenta
43	chr11:113258200-113258400	Enhancers	Placenta Amnion	Placenta Amnion
44	chr11:113258200-113258600	Active TSS	ES-WA7 Cell Line	embryonic stem cell
45	chr11:113258200-113258600	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
46	chr11:113258200-113258600	Flanking Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
47	chr11:113258200-113258600	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
48	chr11:113258200-113258600	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
49	chr11:113258200-113258800	Active TSS	H9 Cell Line	embryonic stem cell
50	chr11:113258200-113258800	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links